Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/09/2014US20140303221 Unknown
10/09/2014US20140303219 Ocular Formulations for Drug-Delivery to the Posterior Segment of the Eye
10/09/2014US20140303217 Dosing regimen for a selective s1p1 receptor agonist
10/09/2014US20140303216 Compositions and methods for inducing disruption of blood vasculature and for reducing angiogenesis
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303214 Transmucosal drug delivery system
10/09/2014US20140303212 METHOD FOR TREATING NEURODEGENERATION USING A p38MAPK INHIBITOR
10/09/2014US20140303211 Compositions containing opioid antagonists
10/09/2014US20140303209 Methods for Treating Disorders or Diseases Associated with Hyperlipidemia and Hypercholesterolemia While Minimizing Side-Effects
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303206 3-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
10/09/2014US20140303205 Modulators of cystic fibrosis transmembrane conductance regulator
10/09/2014US20140303204 Modulators of cystic fibrosis transmembrane conductance regulator
10/09/2014US20140303201 Cancer therapy
10/09/2014US20140303200 Polymorphic Forms of Naltrexone
10/09/2014US20140303199 Inhibitors of rgs proteins
10/09/2014US20140303198 Agent for inhibiting expression of npc1l1 and/or lipg mrna and agent for preventing and/or treating obesity
10/09/2014US20140303197 Methods of treating and preventing leukemia and other cancers of the blood and bone
10/09/2014US20140303195 Combination
10/09/2014US20140303194 Salt forms of organic compound
10/09/2014US20140303191 Use of inhibitors of bruton's tyrosine kinase (btk)
10/09/2014US20140303190 Tyrosine kinase inhibitors
10/09/2014US20140303189 Patch
10/09/2014US20140303187 Compounds and methods for kinase modulation, and indications therefor
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303184 Process for the preparation of a chiral compound
10/09/2014US20140303183 Solution for oral administration
10/09/2014US20140303182 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/09/2014US20140303177 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/09/2014US20140303173 Cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus
10/09/2014US20140303168 Phthalazines as potassium ion channel inhibitors
10/09/2014US20140303166 Cosmetic method for changing the appearance of eyes
10/09/2014US20140303165 Heteroaryl compounds and uses thereof
10/09/2014US20140303164 Therapeutic compounds
10/09/2014US20140303161 Tyrosine kinase inhibitors
10/09/2014US20140303160 Targeting GLI Proteins in Human Cancer by Small Molecules
10/09/2014US20140303155 Pharmaceutical composition and kit for treating bacterial infections
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303148 Pharmaceutical compositions for inhibiting angiogenesis comprising plant-derived natural compound
10/09/2014US20140303146 Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias
10/09/2014US20140303145 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
10/09/2014US20140303140 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
10/09/2014US20140303136 Ceftolozane antibiotic compositions
10/09/2014US20140303132 Lipobalanced long chain testosterone esters for oral delivery
10/09/2014US20140303131 Orally administered corticosteroid compositions
10/09/2014US20140303130 High-strength testosterone undecanoate compositions
10/09/2014US20140303129 Methods of treating testosterone deficiency
10/09/2014US20140303128 Transmucosal hormone delivery system
10/09/2014US20140303127 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
10/09/2014US20140303126 Novel quinuclidine derivatives and medicinal compositions containing the same
10/09/2014US20140303125 Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency
10/09/2014US20140303124 Methods and compositions for the treatment of migraine headaches
10/09/2014US20140303123 Synthesizing functionalized dendrimers within biological settings
10/09/2014US20140303121 Heterocyclic compounds and uses thereof
10/09/2014US20140303120 Methods for the treatment of cancer
10/09/2014US20140303119 Methods, apparatus, and compounds for the treatment of central retinal vein occlusion and other conditions
10/09/2014US20140303118 Synergistic Anti-Diabetic Compositions
10/09/2014US20140303117 Method for Treating Acute Kidney Injury
10/09/2014US20140303115 Lactulose for bowel evacuation
10/09/2014US20140303113 Hepatitis c viral infection treatment using a combination of compounds
10/09/2014US20140303111 Compositions including triciribine and taxanes and methods of use thereof
10/09/2014US20140303110 Effective treatment of tumors and cancer with triciribine and related compounds
10/09/2014US20140303109 Novel Analogs of Curcumin and Methods of Use
10/09/2014US20140303107 Drug formulations
10/09/2014US20140303105 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens
10/09/2014US20140303103 Carbonic anhydrase ix-related markers and use thereof
10/09/2014US20140303101 Compositions for dental care
10/09/2014US20140303100 Compositions for dental care
10/09/2014US20140303099 Compositions and Methods for Improving Cardiovascular Health
10/09/2014US20140303098 Pharmaceutical composition, methods for treating and uses thereof
10/09/2014US20140303097 Pharmaceutical composition, methods for treating and uses thereof
10/09/2014US20140303094 Composition and use thereof in the treatment of anal rhagades
10/09/2014US20140303092 Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infection
10/09/2014US20140303091 Ocular formulations of norketotifen
10/09/2014US20140303086 Endothelium protective materials and methods of use
10/09/2014US20140303085 Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence
10/09/2014US20140303081 Apoptosis-targeting nanoparticles
10/09/2014US20140303077 Albumin fusion proteins
10/09/2014US20140303074 Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription
10/09/2014US20140303073 Antisense antiviral compound and method for treating influenza viral infection
10/09/2014US20140303072 Method of Determining Types I, II, III, IV or V or Methicillin-resistant Staphylococcus aureus (MRSA) in a Biological Sample
10/09/2014US20140303070 Process for the manufacture of ajoene derivatives
10/09/2014US20140303067 Treatment of eosinophilic esophagitis
10/09/2014US20140302213 Method for manufacturing pure guar flour
10/09/2014US20140302185 Composition for the treatment of skin lesions
10/09/2014US20140302182 Methods and compositions for increasing sex steroids and growth hormones
10/09/2014US20140302178 Natural Product for Decreasing Symptoms During Viral Infections
10/09/2014US20140302174 Combination Therapy for Ovarian Cancer
10/09/2014US20140302173 Treatment agent and/or prophylactic agent for side effects of cancer drugs
10/09/2014US20140302171 Cysteine Peptide-Containing Health Drink
10/09/2014US20140302170 Compositions and methods for promoting sleep
10/09/2014US20140302169 Method of Treating Ocular Disorders
10/09/2014US20140302166 Composition of dialysis liquid comprising crystallisation inhibitor substances
10/09/2014US20140302163 Water With Improved Transdermal and Cellular Delivery Properties and Methods Of Manufacture And Use Thereof
10/09/2014US20140302157 Nanoparticle formulations and uses therof
10/09/2014US20140302153 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
10/09/2014US20140302152 Granulates comprising eslicarbazepine acetate
10/09/2014US20140302150 Dpp-iv inhibitor formulations
10/09/2014US20140302148 Cannabinoid formulations
10/09/2014US20140302147 Respirable agglomerates of porous carrier particles and micronized drug
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 7860